Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.

Saved in:
Bibliographic Details
Title: Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.
Authors: Daniels A; The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom., Padariya M; International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdańsk, Poland., Fletcher S; The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom., Ball K; University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom., Singh A; University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom., Carragher N; University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom., Hupp T; International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdańsk, Poland; University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom., Tait-Burkard C; The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom. Electronic address: christine.burkard@roslin.ed.ac.uk., Kalathiya U; International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdańsk, Poland. Electronic address: umesh.kalathiya@ug.edu.pl.
Source: Antiviral research [Antiviral Res] 2024 Aug; Vol. 228, pp. 105949. Date of Electronic Publication: 2024 Jun 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-9096
DOI:10.1016/j.antiviral.2024.105949